ASD

New Pilot Study Suggests Low-Frequency Electromagnetic Fields May Support Children with Autism

June 28, 20264 min read

New Pilot Study Suggests Low-Frequency Electromagnetic Fields May Support Children with Autism

Autism Spectrum Disorder (ASD) affects millions of children worldwide, yet treatment options remain focused primarily on behavioral therapies, educational support, and symptom management. As researchers continue searching for complementary approaches, an exciting new pilot study has explored whether extremely low-frequency electromagnetic fields (ELF-EMFs) may help improve communication, behavior, and overall function.

Published in Brain Sciences in December 2024, the study investigated the effects of a 15-week ELF-EMF treatment program in children with autism. While the research is still in its early stages, the findings offer encouraging directions for future investigation.

Why Look at Electromagnetic Fields?

Growing research suggests that autism is associated with more than differences in behavior and communication. Scientists have also identified changes involving:

  • Neuroinflammation

  • Oxidative stress

  • Cellular signaling

  • Brain connectivity

  • Autonomic nervous system regulation

Previous laboratory and clinical research has suggested that carefully controlled extremely low-frequency electromagnetic fields may influence cellular communication and inflammatory pathways. Researchers have proposed that these fields may help regulate ion movement across cell membranes, potentially supporting healthier cellular function. However, this remains an active area of investigation.

The Study

Researchers enrolled 20 children between the ages of 2 and 13 years with confirmed Autism Spectrum Disorder.

Participants completed a 15-week treatment protocol using the SEQEX system, receiving both daytime and nighttime electromagnetic field programs.

To evaluate progress, standardized clinical assessments were performed before and after treatment, including measures of:

  • Receptive language

  • Expressive language

  • Behavior

  • Attention

  • Parent-reported autism symptoms

Importantly, these are well-established developmental assessment tools commonly used in pediatric practice.

What Did Researchers Find?

The study reported several statistically significant improvements.

Improved Language Skills

Children demonstrated meaningful gains in both:

  • Receptive language (understanding words and language)

  • Expressive language (using language to communicate)

Language development is often one of the greatest challenges for children with autism, making these findings particularly noteworthy.

Better Attention and Behavior

Researchers also observed reductions in:

  • Externalizing behaviors

  • Attention difficulties

  • Behavioral challenges

These improvements were seen across different age groups and were supported by standardized behavioral assessments completed by parents and teachers.

Reduced Autism Symptoms

Parents reported overall improvements in autism-related symptoms, with the strongest changes observed among the youngest children (ages 1.5–5 years). Early intervention is often associated with better developmental outcomes, making this finding particularly interesting for future research.

Excellent Safety Profile

One of the most encouraging aspects of the study was safety.

Researchers reported no significant adverse effects throughout the 15-week treatment period, suggesting the therapy was well tolerated by participating children.

Why Is This Study Important?

This research represents a pilot study, meaning its primary purpose is to determine whether a larger, more rigorous clinical trial is warranted.

Although the results are promising, several limitations should be considered:

  • Only 20 children participated.

  • There was no placebo or sham-treatment control group.

  • The study lasted only 15 weeks.

  • Longer-term outcomes remain unknown.

Because of these limitations, the findings should be viewed as preliminary rather than definitive proof of effectiveness. Larger randomized controlled trials will be needed to confirm whether the improvements were caused by the treatment itself.

The Bigger Picture

Researchers are increasingly recognizing that brain function depends on healthy communication between cells, balanced inflammatory responses, and efficient nervous system regulation.

While behavioral therapies remain the cornerstone of autism care, emerging technologies that support these underlying biological processes may one day become valuable complementary tools.

This study contributes to a growing body of research exploring how non-invasive electromagnetic field therapies might influence neurological health. It opens the door for larger investigations into whether these technologies can safely support children with neuro-developmental conditions.

Final Thoughts

The results of this pilot study are encouraging:

  • Improved language development

  • Better attention and behavior

  • Reduced parent-reported autism symptoms

  • Strong safety profile

However, it is important to emphasize that this research is still in its early stages. The authors themselves conclude that larger, randomized controlled trials are needed before firm clinical recommendations can be made.

Science advances one carefully conducted study at a time—and this research provides an important first step toward understanding whether extremely low-frequency electromagnetic field therapy may have a role in supporting children with Autism Spectrum Disorder in the future.

Reference

Pietramala K, Greco A, Garoli A, Roblin D. Effects of Extremely Low-Frequency Electromagnetic Field Treatment on ASD Symptoms in Children: A Pilot Study. Brain Sciences. 2024;14(12):1293.

Ann Shivas

Ann Shivas

Ann Shivas is the Founder and CEO of LifeLift, an educator, Osteopath, and holder of a Master of Teaching with qualifications to teach at the post-secondary level. She is dedicated to advancing practitioner education in the field of Ion Cyclotron Resonance (ICR) technology powered by SEQEX, helping healthcare professionals confidently integrate this innovative technology into clinical practice. A former professional soccer player, Ann's own athletic injuries sparked a lifelong pursuit of understanding human performance, recovery, and the body's remarkable capacity to adapt. That journey led her to Osteopathy, where she developed a deep appreciation for the interconnected nature of anatomy, physiology, movement, and the body's innate regulatory systems. Over the past decade, Ann has worked with thousands of individuals—including professional athletes and performers from Cirque du Soleil—developing clinical protocols that support rehabilitation, recovery, performance, and wellbeing. Her experience has reinforced one central belief: education empowers better clinical decisions, and better clinical decisions lead to better patient outcomes. As the founder of LifeLift, Ann has built an educational platform dedicated to training practitioners in the safe, ethical, and evidence-informed application of ICR technology. Through comprehensive education, mentorship, and clinical support, she helps practitioners develop the confidence to integrate frequency-based wellbeing technology into patient care within their professional scope of practice. Ann's vision extends far beyond technology. She believes every person deserves the opportunity to embark on a lifelong journey toward greater health, resilience, and fulfillment. Through LifeLift, she is building a global community of practitioners committed to advancing education, inspiring innovation, and improving lives.

Instagram logo icon
Youtube logo icon
LinkedIn logo icon
Back to Blog